Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...

Hormone therapy: Cell growth in some cancers, such as some types of breast cancer and prostate cancer, relies on hormones, and these cancers can be treated with hormone therapy.

It’s true that this butterfly-shaped gland in your neck keeps your metabolism on course, but it is not to blame every time things go south. Experts share thyroid myths to stop believing now. 1 ...

A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types ...

Shari Redstone, the chair and controlling shareholder of Paramount Global, has been diagnosed with thyroid cancer and underwent surgery last month, TheWrap has learned. "Shari Redstone was ...

If you have brittle, thinning hair, consider the connection between your thyroid and hair loss. Hyperthyroidism or hypothyroidism may be the cause, and there are home remedies that can help while ...

The heiress was diagnosed earlier this spring. The disclosure comes as the Paramount sale drags on amid a fight with President Trump over "60 Minutes" edits.

Signs of thyroid problems vary depending on the cause. Hyperthyroidism (overactive thyroid) may cause symptoms like diarrhea, heat sensitivity, and weight loss. Hypothyroidism (underactive thyroid ...

RET fusions are found in about 10 percent of thyroid tumors that originate in follicular cells. This includes anaplastic thyroid cancer, the most aggressive and difficult-to-treat form of the disease.

Paramount Global chair Shari Redstone has disclosed that she underwent surgery for thyroid cancer in May after being diagnosed earlier this year.. A spokesperson for Redstone said, “Shari ...

But 54 years ago, "childhood thyroid cancer was almost unheard of at the time." ... That's a far cry from 2018, when Grace was diagnosed with a germ cell brain tumor, a rare cancer.

Durvalumab (Imfinzi) is a PD-L1–blocking antibody that has 3 indications for non–small cell lung cancer (NSCLC). February 2018: Received approval for treatment of patients with stage III unresectable ...